Human trials to begin on SA-made universal pneumococcal vaccine
South Australian biotech company GPN Vaccines in collaboration with the University of Adelaide has developed a new, universal vaccine against the deadly bacterium Streptococcus pneumoniae.
[Read more about Human trials to begin on SA-made universal pneumococcal vaccine]
New findings show effectiveness of meningococcal B vaccine against gonorrhoea
Researchers at The University of Adelaide have found that the meningococcal B vaccine could improve protection against gonorrhoea in addition to protection against meningococcal B meningitis.
[Read more about New findings show effectiveness of meningococcal B vaccine against gonorrhoea]
Broadening and scaling the reach of mRNA vaccines
The University of Adelaide’s key partner BioCina Pty Ltd has received a grant under the Federal Government’s Cooperative Research Centres Projects (CRC-P) Grants scheme to fund work between the University and co-partner Cytiva.
[Read more about Broadening and scaling the reach of mRNA vaccines]
Health experts recognised for research impact
The University of Adelaide’s Professor Helen Marshall and Dr Trudy Lin have been recognised as South Australia’s 2022 Australian of the Year and Young Australian of the Year respectively.
[Read more about Health experts recognised for research impact]
Life-saving meningococcal B vaccination program continues indefinitely
South Australia's world-leading Meningococcal B Immunisation Program will continue indefinitely after proving it’s been incredibly effective at preventing the illness in high-risk age groups thanks to research at the University of Adelaide.
[Read more about Life-saving meningococcal B vaccination program continues indefinitely]
Adelaide has key role in COVID-19 vaccine human trials
University of Adelaide researchers are playing a leading role in the human trials of Australia’s first needle-free, gene-based COVID-19 vaccine.
[Read more about Adelaide has key role in COVID-19 vaccine human trials]
$1.35M for world-first needle-free Zika virus vaccine
Researchers at the University of Adelaide have been awarded $1.35 million in funding to accelerate development of a world-first vaccine for the Zika virus.
[Read more about $1.35M for world-first needle-free Zika virus vaccine ]
Fears children’s immunisation rates will drop
There are fears parents will skip vital vaccinations for their children and that there may be disease outbreaks, because parents are concerned about taking their children to their GP during the COVID-19 pandemic.
[Read more about Fears children’s immunisation rates will drop]
South Australian scientists band together to fight COVID-19
A team of South Australian scientists are joining forces in the fight against COVID-19 to greater inform the local, national and global response efforts, including the creation of a vaccine.
[Read more about South Australian scientists band together to fight COVID-19]
Breakthrough in Zika virus vaccine
Researchers from the University of Adelaide have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of the disease.